Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-FC516
- Development stage
- Phase 1
- Lead developer
- FindCure Biosciences
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
- Administration
- Intravenous
01
Overview
68Ga-FC516 is a radiopharmaceutical diagnostic PET imaging tracer developed by FindCure Biosciences (ZhongShan) Co., Ltd. for the detection and staging of prostate cancer. It consists of a targeting ligand, FC516, labeled with the positron-emitting radionuclide Gallium-68 (68Ga). The ligand is designed to bind with high affinity to Prostate-Specific Membrane Antigen (PSMA), also known as Glutamate carboxypeptidase 2, which is significantly overexpressed on the surface of prostate cancer cells. By utilizing PET/CT or PET/MRI imaging, 68Ga-FC516 enables the sensitive visualization of primary prostate tumors and metastatic lesions, facilitating accurate disease staging and treatment monitoring. It is currently being evaluated in clinical trials to assess its safety, dosimetry, and diagnostic efficacy compared to other established prostate-targeting tracers.
- Other names
- [68Ga]Ga-FC516Gallium (68Ga) FC516
02
Targets
PSMA (Prostate-specific membrane antigen)
Beyond the preview
Go deeper on 68Ga-FC516.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-FC516.